Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Hormones | 10 | 2019 | 66 | 2.060 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 11 | 2019 | 54 | 1.620 |
Why?
|
| Receptors, Thyroid Hormone | 8 | 2015 | 84 | 1.440 |
Why?
|
| Co-Repressor Proteins | 3 | 2015 | 37 | 1.020 |
Why?
|
| Liver | 11 | 2025 | 1734 | 0.920 |
Why?
|
| Nuclear Proteins | 6 | 2017 | 1265 | 0.720 |
Why?
|
| Thyroid Gland | 4 | 2015 | 112 | 0.690 |
Why?
|
| Thyroid Hormone Receptors beta | 5 | 2017 | 19 | 0.690 |
Why?
|
| Triiodothyronine | 5 | 2014 | 63 | 0.630 |
Why?
|
| Hypothyroidism | 4 | 2017 | 89 | 0.620 |
Why?
|
| Energy Metabolism | 4 | 2025 | 765 | 0.580 |
Why?
|
| Repressor Proteins | 4 | 2009 | 810 | 0.540 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 2530 | 0.520 |
Why?
|
| Cholesterol | 4 | 2019 | 525 | 0.500 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2015 | 65 | 0.490 |
Why?
|
| Sulfotransferases | 3 | 2004 | 27 | 0.470 |
Why?
|
| Fructose | 3 | 2021 | 62 | 0.470 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 3 | 2019 | 5 | 0.380 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 1695 | 0.360 |
Why?
|
| Animals | 30 | 2025 | 33719 | 0.320 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 3 | 2019 | 37 | 0.300 |
Why?
|
| Hepatocytes | 2 | 2008 | 225 | 0.290 |
Why?
|
| Thyroxine | 4 | 2019 | 65 | 0.280 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2025 | 175 | 0.280 |
Why?
|
| Thyrotropin | 4 | 2019 | 58 | 0.260 |
Why?
|
| Mice, Knockout | 8 | 2019 | 3715 | 0.250 |
Why?
|
| Protein Binding | 6 | 2015 | 1743 | 0.240 |
Why?
|
| Mice | 18 | 2023 | 17486 | 0.220 |
Why?
|
| Succinic Acid | 1 | 2022 | 14 | 0.210 |
Why?
|
| 5' Untranslated Regions | 1 | 2002 | 59 | 0.200 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2014 | 23 | 0.200 |
Why?
|
| Liver X Receptors | 2 | 2014 | 20 | 0.200 |
Why?
|
| Triglycerides | 2 | 2021 | 562 | 0.190 |
Why?
|
| Systems Analysis | 1 | 2021 | 14 | 0.190 |
Why?
|
| Metabolomics | 1 | 2025 | 409 | 0.190 |
Why?
|
| Introns | 1 | 2002 | 302 | 0.190 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 68 | 0.190 |
Why?
|
| Transcription Factors | 3 | 2023 | 2585 | 0.180 |
Why?
|
| Lipogenesis | 2 | 2018 | 59 | 0.180 |
Why?
|
| Fibroblast Growth Factors | 2 | 2014 | 154 | 0.180 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 100 | 0.180 |
Why?
|
| Food Deprivation | 1 | 2020 | 29 | 0.170 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2020 | 17 | 0.170 |
Why?
|
| Glucagon | 1 | 2020 | 185 | 0.170 |
Why?
|
| Glucosides | 1 | 2020 | 46 | 0.170 |
Why?
|
| Exons | 1 | 2002 | 795 | 0.170 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2019 | 14 | 0.160 |
Why?
|
| Benzhydryl Compounds | 1 | 2020 | 67 | 0.160 |
Why?
|
| Signal Transduction | 6 | 2017 | 4494 | 0.160 |
Why?
|
| Mutation | 5 | 2017 | 5773 | 0.150 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2018 | 9 | 0.150 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2018 | 8 | 0.150 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2018 | 8 | 0.150 |
Why?
|
| Insulin | 2 | 2021 | 1197 | 0.150 |
Why?
|
| Glucose | 1 | 2023 | 865 | 0.150 |
Why?
|
| Fructose Intolerance | 1 | 2017 | 3 | 0.150 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2018 | 75 | 0.150 |
Why?
|
| Rats | 6 | 2025 | 3631 | 0.140 |
Why?
|
| Pituitary Gland | 2 | 2014 | 84 | 0.130 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 3871 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2019 | 1101 | 0.130 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 137 | 0.120 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 675 | 0.120 |
Why?
|
| Body Weight | 1 | 2019 | 999 | 0.120 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2014 | 242 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 114 | 0.120 |
Why?
|
| Gene Expression | 2 | 2011 | 1569 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2015 | 422 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 76 | 0.120 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 568 | 0.120 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 534 | 0.120 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 207 | 0.120 |
Why?
|
| Lipotropic Agents | 1 | 2014 | 6 | 0.120 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2014 | 13 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 4344 | 0.110 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2014 | 59 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 464 | 0.110 |
Why?
|
| Lipids | 4 | 2023 | 514 | 0.110 |
Why?
|
| RNA, Messenger | 5 | 2021 | 2815 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 1584 | 0.110 |
Why?
|
| Regeneration | 1 | 2015 | 202 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 752 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 369 | 0.110 |
Why?
|
| Ligands | 2 | 2012 | 533 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 187 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 428 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 490 | 0.100 |
Why?
|
| Retinoid X Receptors | 2 | 2010 | 33 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 773 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2014 | 201 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2003 | 287 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2014 | 296 | 0.100 |
Why?
|
| Chromatin | 1 | 2015 | 552 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 560 | 0.100 |
Why?
|
| Cell Line | 4 | 2015 | 2774 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 382 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 352 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2017 | 3046 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2011 | 112 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2014 | 383 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2015 | 1019 | 0.090 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2007 | 33 | 0.090 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 473 | 0.090 |
Why?
|
| PPAR alpha | 1 | 2010 | 53 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1907 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 2047 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 66 | 0.080 |
Why?
|
| Male | 15 | 2025 | 60034 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1641 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2009 | 293 | 0.080 |
Why?
|
| Species Specificity | 1 | 2009 | 549 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 4 | 2017 | 1338 | 0.080 |
Why?
|
| Base Sequence | 2 | 2003 | 3093 | 0.070 |
Why?
|
| Tosyl Compounds | 1 | 2007 | 21 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1308 | 0.070 |
Why?
|
| Anilides | 1 | 2007 | 48 | 0.070 |
Why?
|
| Nitriles | 1 | 2007 | 146 | 0.070 |
Why?
|
| Binding, Competitive | 2 | 2004 | 179 | 0.070 |
Why?
|
| Obesity | 1 | 2018 | 2226 | 0.070 |
Why?
|
| Humans | 13 | 2023 | 123146 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1528 | 0.070 |
Why?
|
| Acetylation | 2 | 2017 | 165 | 0.070 |
Why?
|
| Receptors, Calcitriol | 1 | 2006 | 71 | 0.060 |
Why?
|
| Receptors, Androgen | 2 | 2007 | 409 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 1012 | 0.060 |
Why?
|
| Coenzyme A | 1 | 2025 | 5 | 0.060 |
Why?
|
| Pyruvate Kinase | 1 | 2025 | 10 | 0.060 |
Why?
|
| Adipocytes | 1 | 2006 | 158 | 0.060 |
Why?
|
| Hormone Antagonists | 1 | 2004 | 63 | 0.060 |
Why?
|
| 5' Flanking Region | 1 | 2004 | 9 | 0.060 |
Why?
|
| Mifepristone | 1 | 2004 | 138 | 0.060 |
Why?
|
| Nuclear Matrix | 1 | 2004 | 27 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2698 | 0.060 |
Why?
|
| Binding Sites | 2 | 2004 | 1292 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 49 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2003 | 88 | 0.050 |
Why?
|
| Succinates | 1 | 2022 | 20 | 0.050 |
Why?
|
| Sex Factors | 2 | 2004 | 1255 | 0.050 |
Why?
|
| Transcription Initiation Site | 1 | 2002 | 32 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 44 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 2848 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1211 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2021 | 118 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 893 | 0.050 |
Why?
|
| Gene Duplication | 1 | 2002 | 358 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2002 | 346 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 519 | 0.040 |
Why?
|
| Lipolysis | 1 | 2020 | 82 | 0.040 |
Why?
|
| Calcification, Physiologic | 1 | 2019 | 22 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 353 | 0.040 |
Why?
|
| Epinephrine | 1 | 2020 | 174 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2015 | 674 | 0.040 |
Why?
|
| Bone Development | 1 | 2019 | 56 | 0.040 |
Why?
|
| Receptors, Somatotropin | 1 | 1998 | 9 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 908 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 204 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 683 | 0.040 |
Why?
|
| Intestines | 1 | 2022 | 571 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1515 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2018 | 41 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 54 | 0.040 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 14 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 2390 | 0.040 |
Why?
|
| Protein Phosphatase 2C | 1 | 2018 | 55 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1680 | 0.040 |
Why?
|
| Female | 8 | 2018 | 65443 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 285 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 513 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2018 | 359 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2021 | 847 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 1998 | 311 | 0.030 |
Why?
|
| Bone Density | 1 | 2019 | 311 | 0.030 |
Why?
|
| Weight Gain | 1 | 2019 | 401 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 1760 | 0.030 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2015 | 5 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2015 | 28 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 1002 | 0.030 |
Why?
|
| Xenopus | 1 | 2015 | 107 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 740 | 0.030 |
Why?
|
| NAD | 1 | 2015 | 48 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 649 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 88 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2020 | 1114 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 46 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 95 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 696 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 239 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4268 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 370 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 617 | 0.030 |
Why?
|
| Hyperthyroidism | 1 | 2014 | 26 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1059 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 478 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 526 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2014 | 77 | 0.030 |
Why?
|
| Transfection | 2 | 2006 | 1068 | 0.030 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2012 | 9 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 867 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 174 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 4705 | 0.020 |
Why?
|
| Genes, erbA | 1 | 2011 | 1 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 165 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4221 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1611 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 793 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 1390 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2010 | 79 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2011 | 527 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 937 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 101 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6372 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 410 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1293 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2007 | 313 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2006 | 56 | 0.020 |
Why?
|
| Calcitriol | 1 | 2006 | 80 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 1062 | 0.020 |
Why?
|
| Androgens | 1 | 2007 | 256 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2006 | 247 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2004 | 52 | 0.020 |
Why?
|
| RNA Interference | 1 | 2006 | 496 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 664 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 1338 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 1442 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 19068 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 19093 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 25964 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1677 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3277 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 29029 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 6205 | 0.010 |
Why?
|